Automated Analyzer Market, by Type (Immuno based Analyzer, Hematology Analyzer, Routine Biochemistry Analyzer, Others), Application (Clinical Analysis, Industrial Analysis, Drug Discovery, Chemical Analysis, Others), End User (Healthcare, Oil & Gas, Chemical, Others), Regional Analysis (North America, Europe, Asia-Pacific, LAMEA): Global Opportunity Analysis and Industry Forecast, 2019–2026

Global Automated Analyzer Market Overview 2026:

Automated analyzer is a clinical laboratory device, which is designed to measure concentrations of several chemical ions and biological sample characteristics, with negligible human support. These devices help to increase the number of tests conducted by an individual, helping in eliminating human errors, reducing the variation of results, and increasing the accuracy & precision. Automated analyzers are manufactured to check properties of plasma, blood, serum and other fluids which may help in the diagnosis of the disease.

Driving Forces of Automated Analyzer Market:

Digital transformation of medical & clinical laboratories and adoption of Internet of Things for automation of laboratories are the significant automated analyzer market drivers

Automation of the regular medical, clinical and chemical laboratory processes with the adoption of Internet of Things (IoT) is a major driving factor for the automated analyzer market growth. Increasing demand for integrated healthcare infrastructure and obligation from the governments and end users for the adoption of automation technology to the existed systems to serve the more patients in the less span of time and avoid the human errors in the diagnosis will boost growth of the market. In addition, increase in the number of aged population across the globe and detection of health problems by using the blood and urine analysis through the automated analyzers are projected to enhance the growth of the market size. Moreover, increase in the demand for these analyzers from the hospitals, clinics and research laboratories for disease diagnosis, manufacturers are the factors eventually leading to the improvement the automated analyzers by updating the technology to provide more efficient and accurate instruments, which is further expected to propel the market growth during the projected time. Also, growing prevalence of blood disorders, metabolic abnormalities, liver failures and other diseases related to diagnosis are increasing the demand of automated analyzers.

Constant innovation in the automation technology is anticipated to create significant investment opportunities for the growth of automated analyzer market

Continuous advancements in the automation technology is demanding the introduction of many innovative instruments, creating substantial growth opportunities in the automated analyzer market in the coming years. In addition, growing requirement of automation and technical advancements in the medical and hospitals sectors and increasing trend for the automation of the laboratories are anticipated to boost the automated analyzer market growth in the near future.

Automated Analyzer Market Segmentation, by Type:

Immuno based analyzer type is predicted to be lucrative in the estimated period

Immuno based analyzer type is projected to grow at a faster rate during the forecast period since these analyzers are becoming important tools to detect proteins in clinical laboratories. In addition, immuno-analysis is a strong diagnostic tool to measure cancer, drugs in the blood, hepatitis, fertility disorders and others diagnostic applications; these applications are projected to enhance the market growth in the projected time. These advancements in the immune-based analyzers help to detect irregularities in the patient’s body, which is estimated to further propel the market size in the coming years. Hematology analyzers type held the highest market size and accounted for the majority of the automated analyzer market share in 2018. Hematology analyzers in the morphological and cellular analysis are being used widely to study the physiological condition of the cells. Furthermore, these analyzers are predominantly used for differential leukocyte analysis and cell counts; which is predicted to enhance the market size in the estimated time.
 
Automated Analyzer Market, by Application:

Clinical analysis application accounted for the majority of the market share in 2018 and is projected to continue its growth in the projected time

Clinical analysis application registered for the highest automated analyzer market size in 2018; it is estimated to grow at a notable rate and is predicted to produce major revenue during the forecast period. This growth is attributed to wide usage of automated analyzers in the clinical pathology for the analysis of body fluids, which is advantageous in therapeutics and diagnosis of the diseases. Along with clinical analysis, the market for chemical analysis and drug discovery will witness a noteworthy growth during the estimated period. This is majorly because of growing adoption of automated analyzers by the pharmaceutical and chemical manufacturers for drug detection and chemical constituent’s analysis in the reaction mixture. 

Automated Analyzer Market, by End User:

Healthcare accounted for highest market share and is predicted to be most lucrative till the end of 2026

Chemical end users will witness a notable growth rate during the forecast period. This growth is attributed to automated analyzers being useful for the analysis of chemical reactions such as protein synthesis, impurity detection, determination of chemicals and other reactions. Furthermore, automated analyzers enable the researchers to determine the concentration of the chemical constituents in the reaction substance, which is estimated to impel the growth of the market in the future time. Healthcare end user accounted the largest market size, it is anticipated to continue its growth, growing at a fast rate during the forecast period. This growth is mainly owing to rise in the initiatives towards clinical and medical laboratories automation across the globe. In addition, increase in the number of patients, who are suffering from blood disorders, infectious diseases and growing the investments on development of healthcare infrastructure is also anticipated drive the market size in the forecast period.
 
Automated Analyzer Market, by Region:

Asia-Pacific region will have huge investment opportunities for the market investors to grow over the coming years

Asia-Pacific region will witness to grow at a faster rate and is anticipated to create huge investment opportunities in the forecast time. This growth is majorly because of rise in the consciousness among the people about cardiac analysis, allergy testing, blood cell counts and others. In addition, increase in the number of blood disorder patients and growing awareness about healthcare and increase in the number of pharmaceutical companies in the Asia-Pacific region are projected to boost the growth of the market in the coming years. 
North America region has dominated the global automated analyzer market and accounted for the majority of the market share in 2018 and is projected to continue its growth during the projected period. This dominance is attributed to the existence of improved healthcare infrastructure and major manufacturers increasing the investments in R&D activities across the region. Moreover, increase in the initiatives by the government about automation of diagnosis analyzers and presence of huge number of chemical and pharmaceutical manufacturers adopting automated analyzers for R&D activities are projected to boost the market growth in North America region.

To explore more about automated analyzer market, get in touch with our analysts here. 
https://www.researchdive.com/connect-to-analyst/98

Key Participants in Global Automated Analyzer Market:

Product development and mergers & acquisitions are the most common strategies followed by the market players

Source: Research Dive Analysis

The top gaining automated analyzer market players include Thermo Fisher Scientific Inc., HORIBA, Ltd., Danaher, F. Hoffmann-La Roche Ltd., Siemens, ELITechGroup, Ortho Clinical Diagnostics, BD, Hudson Robotics, Erba Mannheim and among others. These manufacturers are adopting new strategies such as new technology introduction, new product launches, R&D investments, joint ventures, mergers & acquisitions and geographical expansions to rise their position in the overall automated analyzer industry. 

Erba Mannheim has launched new product “EC90 electrolyte analyzer” at MEDICA in 2019 International Trade Fair on November, which is upcoming generation of chemistry, immunoassay and hematology systems. The EC 90 electrolyte analyzer system measures K+, Ca 2+, Cl- and Na+ ions from serum, blood, plasma and urine by using sensors.
 

Source: Research Dive Analysis